Market Cap 726.49M
Revenue (ttm) 348.88M
Net Income (ttm) 42.42M
EPS (ttm) N/A
PE Ratio 10.87
Forward PE 34.12
Profit Margin 12.16%
Debt to Equity Ratio 0.01
Volume 272,730
Avg Vol 973,482
Day's Range N/A - N/A
Shares Out 148.57M
Stochastic %K 23%
Beta 1.59
Analysts Strong Sell
Price Target $9.67

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
Monticello4
Monticello4 Mar. 3 at 5:09 PM
$MDXG Someone should take these two out behind the shed and put them out of their misery...talk about 2 stinkers...jeeze
0 · Reply
Monticello4
Monticello4 Mar. 3 at 2:09 PM
0 · Reply
Monticello4
Monticello4 Mar. 3 at 2:01 PM
0 · Reply
Monticello4
Monticello4 Mar. 3 at 1:51 PM
$MDXG Moonbags says shorts have not learned their lesson...
0 · Reply
Monticello4
Monticello4 Mar. 3 at 1:45 PM
$MDXG As of February 2026, MiMedx Group, Inc. (MDXG) has a significant institutional ownership structure: Total Institutional Ownership: Approximately 70.36% of the shares are held by institutional investors. Largest Shareholder: Essex Woodlands Management is the largest institutional shareholder, holding 19.08% of the shares. Other Major Shareholders: BlackRock, Inc. and Vanguard Group Inc. are also significant institutional investors, holding 6.36% and 2.47% of the shares respectively. Total Shares Held: Institutional investors have purchased a total of 20,119,845 shares in the last 24 months, representing approximately $138.58 million in transactions. This data indicates a strong presence of institutional investors in MiMedx Group, reflecting their confidence in the company's future performance.
0 · Reply
Gov_Researcher
Gov_Researcher Mar. 3 at 1:30 PM
$MDXG sad little people
1 · Reply
Mobagri
Mobagri Mar. 3 at 1:18 PM
$MDXG no catalyst coming up. No prospects. No positive news from CMS. No financial institutions interested in buying shares. What a scam. $4.50 target price
1 · Reply
biomaster22
biomaster22 Mar. 2 at 10:59 PM
$MDXG total pos shit another useless biotech ceo and a BOD that just steals free shares
0 · Reply
Monticello4
Monticello4 Mar. 2 at 10:49 PM
$MDXG pump the lies, dump the truth...
0 · Reply
Omstapocus
Omstapocus Mar. 2 at 5:46 PM
$MDXG If there was ever a time for MDXG to buy back stock it would be now. What would be more positively symbolic is for each board member to purchase stock to demonstrate confidence in their/our company. It is shameful that they have not done so. Maybe some “ free ride quilt” might prevail? Since wound care will at best be flat until all shakes out, announcements for Surgical Applications and their positive clinical and money saving outcomes is most critical NOW . An aggressive marketing team would help !!!
2 · Reply
Latest News on MDXG
MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 7:07 PM EST - 5 days ago

MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript


MIMEDX to Participate in Upcoming Investor Conferences

Nov 10, 2025, 4:01 PM EST - 4 months ago

MIMEDX to Participate in Upcoming Investor Conferences


MiMedx: Breakout Setup Into A Policy Overhaul

Nov 4, 2025, 9:56 AM EST - 4 months ago

MiMedx: Breakout Setup Into A Policy Overhaul


MiMedx Group, Inc. (MDXG) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 6:56 PM EDT - 4 months ago

MiMedx Group, Inc. (MDXG) Q3 2025 Earnings Call Transcript


MIMEDX Announces Record Revenue for Third Quarter 2025

Oct 29, 2025, 4:01 PM EDT - 4 months ago

MIMEDX Announces Record Revenue for Third Quarter 2025


MIMEDX Announces Launch of EPIXPRESS®

Oct 6, 2025, 9:28 AM EDT - 5 months ago

MIMEDX Announces Launch of EPIXPRESS®


MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:01 PM EDT - 7 months ago

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript


MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 30, 2025, 8:00 AM EDT - 7 months ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.


MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 10 months ago

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:50 PM EST - 1 year ago

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:38 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 9:10 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:33 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript


MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 2 years ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing


MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:46 PM EST - 2 years ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript


Monticello4
Monticello4 Mar. 3 at 5:09 PM
$MDXG Someone should take these two out behind the shed and put them out of their misery...talk about 2 stinkers...jeeze
0 · Reply
Monticello4
Monticello4 Mar. 3 at 2:09 PM
0 · Reply
Monticello4
Monticello4 Mar. 3 at 2:01 PM
0 · Reply
Monticello4
Monticello4 Mar. 3 at 1:51 PM
$MDXG Moonbags says shorts have not learned their lesson...
0 · Reply
Monticello4
Monticello4 Mar. 3 at 1:45 PM
$MDXG As of February 2026, MiMedx Group, Inc. (MDXG) has a significant institutional ownership structure: Total Institutional Ownership: Approximately 70.36% of the shares are held by institutional investors. Largest Shareholder: Essex Woodlands Management is the largest institutional shareholder, holding 19.08% of the shares. Other Major Shareholders: BlackRock, Inc. and Vanguard Group Inc. are also significant institutional investors, holding 6.36% and 2.47% of the shares respectively. Total Shares Held: Institutional investors have purchased a total of 20,119,845 shares in the last 24 months, representing approximately $138.58 million in transactions. This data indicates a strong presence of institutional investors in MiMedx Group, reflecting their confidence in the company's future performance.
0 · Reply
Gov_Researcher
Gov_Researcher Mar. 3 at 1:30 PM
$MDXG sad little people
1 · Reply
Mobagri
Mobagri Mar. 3 at 1:18 PM
$MDXG no catalyst coming up. No prospects. No positive news from CMS. No financial institutions interested in buying shares. What a scam. $4.50 target price
1 · Reply
biomaster22
biomaster22 Mar. 2 at 10:59 PM
$MDXG total pos shit another useless biotech ceo and a BOD that just steals free shares
0 · Reply
Monticello4
Monticello4 Mar. 2 at 10:49 PM
$MDXG pump the lies, dump the truth...
0 · Reply
Omstapocus
Omstapocus Mar. 2 at 5:46 PM
$MDXG If there was ever a time for MDXG to buy back stock it would be now. What would be more positively symbolic is for each board member to purchase stock to demonstrate confidence in their/our company. It is shameful that they have not done so. Maybe some “ free ride quilt” might prevail? Since wound care will at best be flat until all shakes out, announcements for Surgical Applications and their positive clinical and money saving outcomes is most critical NOW . An aggressive marketing team would help !!!
2 · Reply
Monticello4
Monticello4 Mar. 2 at 4:17 PM
$MDXG Good morning Moonbags...how is your day going?
0 · Reply
Monticello4
Monticello4 Mar. 2 at 3:49 PM
$MDXG oops
0 · Reply
Mobagri
Mobagri Mar. 2 at 2:43 PM
$MDXG worse coming
2 · Reply
Mobagri
Mobagri Mar. 2 at 2:42 PM
$MDXG like I said
1 · Reply
Mobagri
Mobagri Mar. 2 at 2:41 PM
$MDXG like I said
0 · Reply
Mobagri
Mobagri Mar. 2 at 2:40 PM
$MDXG another stupid statement from KY jelly lover
0 · Reply
Mobagri
Mobagri Mar. 2 at 2:38 PM
$MDXG new lows again. Congrats to Monticello and all other employees
0 · Reply
Monticello4
Monticello4 Mar. 1 at 3:48 PM
$MDXG ORGO down 45% since Dec 24th… MDXG down 29% since that same date...
1 · Reply
Mobagri
Mobagri Mar. 1 at 2:27 PM
$MDXG another brutal week with new lows coming in less than 24 hours.
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 28 at 1:26 AM
$MDXG Current Stock Price: $4.90 Contracts to trade: $5.0 MDXG Mar 20 2026 Call Entry: $0.05 Exit: $0.10 ROI: 94% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Monticello4
Monticello4 Feb. 27 at 9:04 PM
1 · Reply
Monticello4
Monticello4 Feb. 27 at 7:06 PM
$MDXG Gotta give you credit Mobags, your call to buy ORGO was awesome...busted thru $7 and $8 like a hot knife thru butter...and as you described yourself, only a sophisticated investor like you could have seen that opportunity...wonder if you have any more pearls of stupidity for us...
1 · Reply